Core set items selected for 11 domains for the CRISS. Modified from Khanna, et al. Ann Rheum Dis 2008; 67:703–9, with permission.
Soluble biomarkers |
Acute phase reactants ESR and/or CRP |
Cardiac |
Cardiac echocardiogram with Doppler† |
Right heart catheterization |
6-Minute Walk Test* |
Borg Dyspnea Instrument* |
Digital ulcers |
Active digital tip ulcer count on the volar surface |
VAS digital ulcer (part of Scleroderma HAQ-DI) |
Gastrointestinal |
Body mass index |
Validated GI tract VAS or other SSc-validated GI questionnaire |
Global health |
VAS/Likert scale for patient global severity |
VAS/Likert scale for physician global severity |
Scleroderma-related health transition by patient |
Scleroderma-related health transition by physician** |
Health-related quality of life and function |
HAQ-DI |
VAS pain scale from the HAQ-DI |
Short Form-36 score, version 2 |
Musculoskeletal |
Tender Joint Count |
Tendon friction rubs assessed by the physician** |
Serum creatinine phosphokinase, aldolase |
Pulmonary |
Pulmonary function testing |
Validated measure of dyspnea |
Breathing VAS from the Scleroderma HAQ |
HRCT of the lungs: quantifiable scale* |
Raynaud’s phenomenon |
Raynaud’s condition score |
VAS (part of S-HAQ) |
Renal |
Calculated creatinine clearance based on serum creatinine (Cockroft-Gault or MDRD formula) |
Pre-defined renal crisis (presence or absence) |
Skin |
Modified Rodnan Skin Score (range 0–51) |
VAS/Likert of patient global assessment for skin activity** |
VAS/Likert of physician global assessment for skin activity** |
Durometer |
↵† Standardized central reading mechanism strongly encouraged;
↵* if relevant to the study;
↵** Items were based on Steering Committee and SCTC consensus despite lack of full validation. CRISS: Combined Response Index for SSc; ESR: erythrocyte sedimentation rate; HAQ-DI: Health Assessment Questionnaire Disability Index; VAS: visual analog scale; HRCT: high resolution computed tomography; MDRD: modification of diet in renal disease.